Immune-tolerance to human iPS-derived neural progenitors xenografted into the immature cerebellum is overridden by species-specific differences in differentiation timing.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 01 2021
Historique:
received: 27 12 2019
accepted: 09 12 2020
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 11 8 2021
Statut: epublish

Résumé

We xeno-transplanted human neural precursor cells derived from induced pluripotent stem cells into the cerebellum and brainstem of mice and rats during prenatal development or the first postnatal week. The transplants survived and started to differentiate up to 1 month after birth when they were rejected by both species. Extended survival and differentiation of the same cells were obtained only when they were transplanted in NOD-SCID mice. Transplants of human neural precursor cells mixed with the same cells after partial in vitro differentiation or with a cellular extract obtained from adult rat cerebellum increased survival of the xeno-graft beyond one month. These findings are consistent with the hypothesis that the slower pace of differentiation of human neural precursors compared to that of rodents restricts induction of immune-tolerance to human antigens expressed before completion of maturation of the immune system. With further maturation the transplanted neural precursors expressed more mature antigens before the graft were rejected. Supplementation of the immature cells suspensions with more mature antigens may help to induce immune-tolerance for those antigens expressed only later by the engrafted cells.

Identifiants

pubmed: 33436685
doi: 10.1038/s41598-020-79502-9
pii: 10.1038/s41598-020-79502-9
pmc: PMC7803978
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

651

Références

J Neurosci. 2014 Nov 26;34(48):16153-61
pubmed: 25429155
Neuron. 2015 Mar 4;85(5):982-97
pubmed: 25741724
Exp Neurol. 2016 Aug;282:78-85
pubmed: 27235932
Cerebellum Ataxias. 2017 Sep 21;4:16
pubmed: 28944066
Nat Cell Biol. 2003 Nov;5(11):959-66
pubmed: 14562057
PLoS One. 2009 Aug 06;4(8):e6529
pubmed: 19657394
J Neurosci. 2006 Nov 1;26(44):11413-22
pubmed: 17079670
J Neuroimmunol. 1997 Apr;74(1-2):55-61
pubmed: 9119979
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18644-8
pubmed: 16352714
J Biol Chem. 1995 Apr 14;270(15):8730-8
pubmed: 7721778
Vet Pathol. 2017 Sep;54(5):855-869
pubmed: 28355107
Exp Brain Res. 1995;104(2):227-42
pubmed: 7672016
Stem Cells. 2012 Dec;30(12):2657-71
pubmed: 22961761
Nat Methods. 2012 Sep;9(9):856-8; author reply 858
pubmed: 22936164
Stem Cells Transl Med. 2013 Nov;2(11):862-70
pubmed: 24113065
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4374-9
pubmed: 23440189
Cancer Res. 2008 Jan 1;68(1):292-300
pubmed: 18172322
Glia. 2018 Sep;66(9):1929-1946
pubmed: 29732603
J Neurosci Res. 2002 Sep 15;69(6):976-86
pubmed: 12205691
Nat Methods. 2009 Apr;6(4):271-3
pubmed: 19270699
Neuron. 2013 Feb 6;77(3):440-56
pubmed: 23395372
Stem Cells Dev. 2014 Sep 15;23(18):2129-42
pubmed: 24325299
Cell Stem Cell. 2017 Nov 2;21(5):569-573
pubmed: 29100010
Development. 2018 Jun 26;145(12):
pubmed: 29945985
Acta Neurobiol Exp (Wars). 2013;73(1):88-101
pubmed: 23595286
Exp Brain Res. 1985;60(1):204-8
pubmed: 3930278
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21795-800
pubmed: 21098272
Nat Biotechnol. 2019 Oct;37(10):1137-1144
pubmed: 31427818
Sci Rep. 2019 Jan 24;9(1):651
pubmed: 30679601
PLoS One. 2015 Feb 23;10(2):e0116413
pubmed: 25706286
Nature. 1953 Oct 3;172(4379):603-6
pubmed: 13099277
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8331-4
pubmed: 3186728
J Neurosci. 2002 Aug 15;22(16):7132-46
pubmed: 12177209
J Neurosci. 2016 Nov 9;36(45):11544-11558
pubmed: 27911758
Cell Stem Cell. 2008 Jun 5;2(6):553-65
pubmed: 18522848
JCI Insight. 2016 Nov 17;1(19):e88632
pubmed: 27882348
Ann Neurol. 2018 Dec;84(6):950-956
pubmed: 30286516
Methods Mol Biol. 2002;198:327-40
pubmed: 11951636
Nat Biotechnol. 1998 Nov;16(11):1040-4
pubmed: 9831032
J Immunol. 2014 Feb 15;192(4):1938-45
pubmed: 24415782
Sci Rep. 2017 Oct 11;7(1):12996
pubmed: 29021610
Ann Neurol. 2003 Sep;54(3):403-14
pubmed: 12953276
Exp Neurol. 1994 Nov;130(1):151-67
pubmed: 7821391
Chimerism. 2011 Apr;2(2):55-7
pubmed: 21912720
Nature. 2003 Oct 30;425(6961):968-73
pubmed: 14555960
J Neuroimmunol. 1988 Apr;18(1):37-48
pubmed: 3346369
Front Mol Neurosci. 2018 Apr 30;11:136
pubmed: 29760649
Neuroreport. 2013 Dec 18;24(18):1010-5
pubmed: 24257248
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5856-61
pubmed: 18391196
PLoS One. 2013;8(3):e60438
pubmed: 23536908
Cell Stem Cell. 2015 Jan 8;16(1):33-8
pubmed: 25465116
Biotech Histochem. 1991;1(1):29-34
pubmed: 1716157
Exp Neurol. 2014 Apr;254:90-8
pubmed: 24440640

Auteurs

Giulia Nato (G)

Department of Neuroscience Rita Levi-Montalcini, University of Turin, Via Cherasco 15, Torino, Italy.
Neuroscience Institute Cavalieri Ottolenghi (NICO), 10043, Orbassano, Torino, Italy.

Alessandro Corti (A)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Elena Parmigiani (E)

Department of Neuroscience Rita Levi-Montalcini, University of Turin, Via Cherasco 15, Torino, Italy.
Neuroscience Institute Cavalieri Ottolenghi (NICO), 10043, Orbassano, Torino, Italy.

Elena Jachetti (E)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Daniele Lecis (D)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Mario Paolo Colombo (MP)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Domenico Delia (D)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.
IFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milano, Italy.

Annalisa Buffo (A)

Department of Neuroscience Rita Levi-Montalcini, University of Turin, Via Cherasco 15, Torino, Italy.
Neuroscience Institute Cavalieri Ottolenghi (NICO), 10043, Orbassano, Torino, Italy.

Lorenzo Magrassi (L)

Neurosurgery, Department of Clinical, Surgical, Diagnostic and Pediatric Science, University of Pavia, Foundation IRCCS Policlinico San Matteo, Pavia, Italy. lorenzo.magrassi@unipv.it.
Istituto Di Genetica Molecolare IGM-CNR, via Abbiategrasso 207, 27100, Pavia, Italy. lorenzo.magrassi@unipv.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH